Heart disease continues to be the leading cause of death in the U.S., but doctors with Corewell Health say thanks to advances ...

“I’m still in shock.” Also on Sunday, volunteers had begun bringing water, food, clothing and other needed goods to people cleaning up their devastated properties.

Data from multiple Phase 2 studies in patients with early cardiogenic shock or acute decompensated heart failure demonstrate that istaroxime infused intravenously can significantly improve cardiac ...

Windtree Therapeutics announces a U.S. patent for istaroxime, a potential treatment for acute heart failure, effective until 2039.